Introduction Between 5 and 25% of patients with cutaneous lupus erythematosus (CLE) can
progress to systemic lupus erythematosus (SLE) during the course of the disease. There is …

Lupus erythematosus is an autoimmune disease that may manifest in a variety of organs
and tissues including the skin, kidney, brain, heart and lung. Many patients present with …

Cutaneous lupus erythematosus (CLE) includes a broad range of dermatologic
manifestations, which may or may not be associated with systemic disease. Recent studies …

SLE is an autoimmune disease that is characterized by the development of autoantibodies
and immunologic attack of different organ systems, including the skin. This review aims to …

Cutaneous lupus erythematosus (CLE) can be an individual disease only involving skin, or
presents as part of the manifestations of SLE. A small proportion of CLE may progress into …

Is systemic lupus erythematosus (SLE) is occurring more frequently now than in decades
past? Despite improvements in the identification of patients with SLE, the development of …

This review summarises a number of current insights into the pathogenesis of SLE. On the
basis of the interaction of environmental factors within a predisposed host, a chronic …

Lupus erythematosus (LE) is a systemic autoimmune disorder associated with polyclonal B-
cell activation resulting in diverse patterns of autoantibody production and a heterogeneous …

Systemic lupus erythematosus (SLE) is a complicated autoimmune disease with female
susceptibility. It is characterized by over-activation of the immune system and deposit of …

Background Cutaneous lupus erythematosus (CLE), occurring with or without systemic
lupus erythematosus (SLE), is a group of inflammatory skin diseases that can be very …